Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China

被引：0
|
作者：
Zhang, Puhong [1 ]
Zhang, Heng [1 ]
Zhu, Dongshan [1 ]
Li, Xian [1 ]
Ji, Jiachao [1 ]
Zhao, Fang [1 ]
Lu, Juming [2 ]
Jia, Weiping [3 ]
Ji, Linong [1 ,4 ]
机构：
[1] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[3] Shanghai 6th Hosp, Dept Endocrinol, Shanghai, Peoples R China
[4] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
989017
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [32] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [33] USE OF INSULIN-BOLUS CALCULATOR FREE STYLE INSULINX® IN DIABETES TYPE-1 PATIENTS TREATED WITH BASAL-BOLUS INSULIN REGIMEN
    Delgado, E.
    Tejera, C.
    Bellido, D.
    Morales, F.
    Porca, C.
    Diaz Perez De Madrid, Jose
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A74 - A74
  • [34] The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
    Ozturkmen, Yuksel Asli
    Avci, Suna
    Calim, Aslihan
    Cetin, Elif Guven
    Demir, Nazan
    Mazi, Emrah Erkan
    Borlu, Fatih
    Altuntas, Yuksel
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 416 - 423
  • [35] Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
    Shimoda, Seiya
    Okubo, Mina
    Koga, Kotaro
    Sekigami, Taiji
    Kawashima, Junji
    Kukidome, Daisuke
    Igata, Motoyuki
    Ishii, Norio
    Shimakawa, Akiko
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Furukawa, Noboru
    Nishida, Kenro
    Araki, Eiichi
    ENDOCRINE JOURNAL, 2015, 62 (02) : 209 - 216
  • [36] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    Kate van Brunt
    Bradley Curtis
    Tibor Ivanyi
    Elemer Balogh
    Corina Chalkiadaki
    Sharon MacLachlan
    David Neasham
    Mireia Raluy-Callado
    Diabetes Therapy, 2016, 7 : 793 - 807
  • [37] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    van Brunt, Kate
    Curtis, Bradley
    Ivanyi, Tibor
    Balogh, Elemer
    Chalkiadaki, Corina
    MacLachlan, Sharon
    Neasham, David
    Raluy-Callado, Mireia
    DIABETES THERAPY, 2016, 7 (04) : 793 - 807
  • [38] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
  • [39] Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
    Pfeiffer, Kathryn M.
    Basse, Amaury
    Lee, Xin Ying
    Waldman, Laura Tesler
    DIABETES THERAPY, 2018, 9 (05) : 1931 - 1944
  • [40] Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
    Kathryn M. Pfeiffer
    Amaury Basse
    Xin Ying Lee
    Laura Tesler Waldman
    Diabetes Therapy, 2018, 9 : 1931 - 1944
12345